ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 352299 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 352299; 2) Community: the network communities that were significantly associated with the response to NSC 352299; 3) Molecule: the relationships between components within communities and NSC 352299; 4) MDR: the compounds that were significantly associated with the NSC 352299.

NSC Compound Enrichment Correlation
NSC 295500 Camptothecin Derivative 0.0202245331784479 0.26466154
NSC 744023 (11aS)-8-(3-{4-[(E)-3-(2-hydroxyphenyl)-3-oxo-1-propenyl]-2-methoxyphenoxy}propoxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0212053315848708 0.11740208
NSC 122750 GELDANAMYCIN 0.021205331584871 -0.20815686
NSC 283440 B633439K049 0.021205331584871 -0.11763017
NSC 305978 Herbimycin Herbimycin A 0.021205331584871 -0.18252034
NSC 627991 Benzo[g]pteridine-2,4-dione, 8-chloro-10-(4-chlorophenyl)- 3-methyl- 0.0212053315848711 -0.12048661
NSC 661420 2-Chloro-3-(1-(4-methyl)piperazino)naphthazarin 0.0212053315848711 -0.24753997
NSC 665549 Azoxydapsone {1,2-bis-[4-(4'-aminophenylsulfonylphenyl)]- diazine-1-oxide} 0.0212053315848711 0.38385888
NSC 678125 1H-indazole, 3-methoxy-1-[(2-methoxyphenyl)methyl]- 5-nitro- 0.0212053315848711 0.21141735
NSC 756140 GSK1220512A 0.0220292715546633 -0.21846663
Total:53  Current:24    [First] [Prev] [Next] [Last]